Literature DB >> 12103457

Does higher cardiovascular response to ECT predict early antidepressant effect?

E S M Saravanan1, B N Gangadhar, N Janakiramaiah, R S Pandey, H S Murthy, D K Subbakrishna.   

Abstract

BACKGROUND: Effects of diencephalic seizure generalization during ECT, e.g., cardiovascular response, may be relevant in indexing its therapeutic potency. A trend for greater rate pressure product (RPP=heart rate x systolic blood pressure) response to modified ECT in responders than in nonresponders is reported. Atropine used in modified ECT is known to increase RPP. This study examined if cardiovascular response during ECT with or without atropine predicts antidepressant effect.
METHODS: Twenty nine consenting, major depressive disorder patients received ECTs. Atropine premedication was randomly withheld in the second or third ECT session. RPP was recorded during ECT. Severity of depression was measured at twice weekly intervals.
RESULTS: Fifteen patients remitted at the end of 2 weeks. These early remitters had significantly higher poststimulus RPP than the rest in the ECT session without atropine but not so in the session with atropine. Cumulative poststimulus RPP predicted the early antidepressant response. Corresponding motor or EEG seizure durations were not associated with antidepressant effect. LIMITATIONS: Most patients continued to receive antidepressants. ECT stimulus laterality was not controlled. The study focussed on only short term antidepressant effects.
CONCLUSIONS: RPP response to ECT recorded under no-atropine condition may reflect its physiological effects relevant to therapeusis and may have the potential to index seizure adequacy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12103457     DOI: 10.1016/s0165-0327(00)00383-9

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  5 in total

1.  Brief vs. ultrabrief pulse ECT: focus on seizure quality.

Authors:  Isabelle Brunner; Michael Grözinger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-07-18       Impact factor: 5.270

2.  Bifrontal ECT for drug-induced psychosis in Parkinson's disease.

Authors:  K Muralidharan; R Thimmaiah; V Chakraborty; S Jain
Journal:  Indian J Psychiatry       Date:  2011-04       Impact factor: 1.759

Review 3.  Two decades of an indigenously developed brief-pulse electroconvulsive therapy device: A review of research work from National Institute of Mental Health and Neurosciences.

Authors:  Preeti Sinha; A ShyamSundar; Jagadisha Thirthalli; B N Gangadhar; Vittal S Candade
Journal:  Indian J Psychiatry       Date:  2016 Jan-Mar       Impact factor: 1.759

4.  Effects of electrical stimulus composition on cardiac electrophysiology in a rodent model of electroconvulsive therapy.

Authors:  Nagendra Madan Singh; T N Sathyaprabha; Jagadisha Thirthalli; Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2018 Jan-Mar       Impact factor: 1.759

5.  Effects of preemptive intravenous paracetamol and ibuprofen on headache and myalgia in patients after electroconvulsive therapy: A placebo-controlled, double-blind, randomized clinical trial.

Authors:  Erol Karaaslan; Sedat Akbas; Ahmet Selim Ozkan; Esra Porgali Zayman
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.